EdgarLookup
4

4 Filing

Company
Eloxx Pharmaceuticals, Inc.
Filed
May 20, 2013
Period of Report
May 17, 2013
Accession Number
0001144204-13-030377
View Document ↗ View on SEC.gov ↗